DSM Firmenich Overview

  • Year Founded
  • 1902

Year Founded

  • Status
  • Public

  • Employees
  • 30,000

Employees

  • Stock Symbol
  • DSFIR

Stock Symbol

  • Investments
  • 84

  • Share Price
  • $109.07
  • (As of Tuesday Closing)

DSM Firmenich General Information

Description

DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from animal feed to medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.

Contact Information

Formerly Known As
Koninklijke DSM N.V., Koninklijke DSM, DSM N.V.
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
AMS
Corporate Office
  • Wurmisweg 576
  • 4303 Kaiseraugst
  • Switzerland
+41 061 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DSM Firmenich Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$109.07 $107.33 $79.72 - $134.16 $28.5B 265M 466K $9.89

DSM Firmenich Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 29,266,867 29,266,867
Revenue 11,499,215 11,499,215 8,821,272 13,530,225
EBITDA 439,323 439,323 1,377,338
Net Income 2,312,395 2,312,395 1,787,385 1,030,964
Total Assets 37,882,054 37,882,054 18,662,935
Total Debt 5,339,081 5,339,081 3,285,826 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DSM Firmenich Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DSM Firmenich‘s full profile, request access.

Request a free trial

DSM Firmenich Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and
Pharmaceuticals
Kaiseraugst, Switzerland
30,000 As of 2023
00.000
000.00 0000-00-00
000000000 00.000

000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nost
000000000000000
Mumbai, India
0000 As of 0000
00000000

00000

pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui off
0000000000000
Basel, Switzerland
00000 As of 0000
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DSM Firmenich Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbott India Corporation Mumbai, India 0000 00000000
Lonza Group Corporation Basel, Switzerland 00000 00000 000000000000 00000
Vetter Pharma Private Debt Financed Ravensburg, Germany 0000 000000000
Perrigo Company Corporation Dublin, Ireland 0000 00.00 000000000 00 00.00
Nestlé Health Science France Corporation Issy-les-moulineaux, France
You’re viewing 5 of 14 competitors. Get the full list »

DSM Firmenich Executive Team (51)

Name Title Board Seat Contact Info
Dimitri de Vreeze Chief Executive Officer
Emmanuel Butstraen Executive Committee Member President Perfumery & Beauty Chief Integration Officer
Ivo Lansbergen President, Animal Nutrition and Health President
Gareth Barker President of DSM Personal Care & Aroma Ingredients
Patrick Niels President of Food & Beverage
You’re viewing 5 of 51 executive team members. Get the full list »

DSM Firmenich Board Members (24)

Name Representing Role Since
00000 000000 Self Board Member 000 0000
000000 00000000-00 Self Board Member 000 0000
0000000 00 000000 DSM Firmenich Chief Executive Officer 000 0000
00000 0000 Self Board Member 000 0000
00000 000 00000000 Self Board Member 000 0000
You’re viewing 5 of 24 board members. Get the full list »

DSM Firmenich Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DSM Firmenich Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DSM Firmenich‘s full profile, request access.

Request a free trial

DSM Firmenich Investments & Acquisitions (84)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Octarine Bio 08-Nov-2023 00000 0000 00.000 Biotechnology
Adare Biome 03-Jul-2023 0000000000 00000 Pharmaceuticals 000000 00
Tasman (Fonterra Cooperative Group / Koninklijke DSM) 01-Jan-2023 00000 0000 Food Products
Prodap 31-Aug-2022 0000000000 000.00 Business/Productivity Software 000 00000
Firmenich 31-May-2022 Merger/Acquisition 000.00 Personal Products 000000000
You’re viewing 5 of 84 investments and acquisitions. Get the full list »

DSM Firmenich Subsidiaries (17)

Company Name Industry Location Founded
Stichting Pensioenfonds DSM Nederland Corporate Pension Heerlen, Netherlands 2014
BioCare Copenhagen Biotechnology Broendby, Denmark 0000
Glycom Biotechnology Horsholm, Denmark 0000
Yantai Andre Pectin Food Products Yantai, China 0000
DSM Venturing Corporate Venture Capital Heerlen, Netherlands 0000
You’re viewing 5 of 17 subsidiaries. Get the full list »

DSM Firmenich ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view DSM Firmenich’s complete esg history, request access »

DSM Firmenich Exits (11)

Company Name Exit Date Exit Type Exit Size Status Buyers
Adaptive3D 29-Sep-2020 00000 00000 00 00.00 Completed
  • 7 buyers
Japan Fine Coatings Company 01-Jan-2016 000000000 00000000 Completed
  • 000 000000000
NanoHolding 09-Nov-2015 00000 00000 00 0000 Completed
  • 7 buyers
Reverdia (Biotechnology) 28-Mar-2012 00000 0000000 Completed
  • 2 buyers
Qolpac 01-Jan-2009 Merger/Acquisition Completed
You’re viewing 5 of 11 exits. Get the full list »

DSM Firmenich FAQs

  • When was DSM Firmenich founded?

    DSM Firmenich was founded in 1902.

  • Who is the CEO of DSM Firmenich?

    Dimitri de Vreeze is the CEO of DSM Firmenich.

  • Where is DSM Firmenich headquartered?

    DSM Firmenich is headquartered in Kaiseraugst, Switzerland.

  • What is the size of DSM Firmenich?

    DSM Firmenich has 30,000 total employees.

  • What industry is DSM Firmenich in?

    DSM Firmenich’s primary industry is Pharmaceuticals.

  • Is DSM Firmenich a private or public company?

    DSM Firmenich is a Public company.

  • What is DSM Firmenich’s stock symbol?

    The ticker symbol for DSM Firmenich is DSFIR.

  • What is the current stock price of DSM Firmenich?

    As of 16-Apr-2024 the stock price of DSM Firmenich is $109.07.

  • What is the current market cap of DSM Firmenich?

    The current market capitalization of DSM Firmenich is $28.5B.

  • What is DSM Firmenich’s current revenue?

    The trailing twelve month revenue for DSM Firmenich is $11.5B.

  • Who are DSM Firmenich’s competitors?

    Abbott India, Lonza Group, Vetter Pharma, Perrigo Company, and Nestlé Health Science France are some of the 14 competitors of DSM Firmenich.

  • What is DSM Firmenich’s annual earnings per share (EPS)?

    DSM Firmenich’s EPS for 12 months was $9.89.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »